Trixeo Aerosphere recommended for approval in the EU by CHMP for the maintenance treatment of COPD... Oct 19
If approved, Forxiga would become the first SGLT2 inhibitor indicated for heart failure with reduced ejection fraction in patients with and without type-2 diabetes... Oct 19
-Advertisements-